Cargando…
Hypoxia-preconditioned mesenchymal stem cells ameliorate ischemia/reperfusion-induced lung injury
BACKGROUND: Hypoxia preconditioning has been proven to be an effective method to enhance the therapeutic action of mesenchymal stem cells (MSCs). However, the beneficial effects of hypoxic MSCs in ischemia/reperfusion (I/R) lung injury have yet to be investigated. In this study, we hypothesized that...
Autores principales: | Liu, Yung-Yang, Chiang, Chi-Huei, Hung, Shih-Chieh, Chian, Chih-Feng, Tsai, Chen-Liang, Chen, Wei-Chih, Zhang, Haibo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5678873/ https://www.ncbi.nlm.nih.gov/pubmed/29117205 http://dx.doi.org/10.1371/journal.pone.0187637 |
Ejemplares similares
-
Hypoxia-preconditioned mesenchymal stem cells prevent renal fibrosis and inflammation in ischemia-reperfusion rats
por: Ishiuchi, Naoki, et al.
Publicado: (2020) -
Hypoxic mesenchymal stem cells ameliorate acute kidney ischemia-reperfusion injury via enhancing renal tubular autophagy
por: Tseng, Wei-Cheng, et al.
Publicado: (2021) -
Dexmedetomidine preconditioning ameliorates kidney ischemia-reperfusion injury
por: Lempiäinen, Juha, et al.
Publicado: (2014) -
DPP-4 enzyme deficiency protects kidney from acute ischemia-reperfusion injury: role for remote intermittent bowel ischemia-reperfusion preconditioning
por: Chen, Yen-Ta, et al.
Publicado: (2017) -
Evolving spectrum of dexmedetomidine preconditioning for Ischemia–reperfusion injury amelioration
por: Kohli, Jasvinder K., et al.
Publicado: (2020)